$NBP Balance Sheet | Understand Stock

$NBP

$1.26 +$0.01 (0.4%) Close

$NBP Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Financial Statements

Income Statement Balance Sheet Cashflow Statement

Consolidated Balance Sheets

In millions of CNY, except per-share amounts

	Q4 FY2025 As of Dec 31, 2025	Q4 FY2024 As of Dec 31, 2024	Q4 FY2023 As of Dec 31, 2023	Q4 FY2022 As of Dec 31, 2022	Q4 FY2021 As of Dec 31, 2021	Q4 FY2020 As of Dec 31, 2020	Q4 FY2019 As of Dec 31, 2019
Assets
Current assets
Cash and cash equivalents
Pro Forma
Total cash and cash equivalents

Short-term restricted cash
Pro Forma
Total short-term restricted cash
Accounts receivable
Contract assets
Short-term investments
Pro Forma
Total short-term investments

Inventories
Prepayments and other receivables
Pro Forma
Total prepayments and other receivables

Current assets of discontinued operations
Pro Forma
Total current assets

Long-term restricted cash
Property, equipment and software
Pro Forma
Total property, equipment and software

Operating lease right-of-use assets
Pro Forma
Total operating lease right-of-use assets

Investments at fair value, available-for-sale debt securities (amortized cost of $0 and $38,727, respectively)
Intangible assets
Pro Forma
Total intangible assets

Goodwill
Pro Forma
Total goodwill
Investments accounted for using the equity method
Investments at fair value, equity securities
Other non-current assets
Pro Forma
Total other non-current assets

Non-current assets of discontinued operations
Pro Forma
Total assets

Liabilities and shareholders' equity
Current liabilities
Short-term bank borrowings
Pro Forma
Total short-term bank borrowings

Accruals and other payables (including amounts with related parties of $1,131, $0, and $0, respectively - Note 17)
Pro Forma
Total accruals and other payables (including amounts with related parties of $1,131, $0, and $0, respectively - Note 17)

Contract liabilities, current
Other current liabilities
Operating lease liabilities, current
Pro Forma
Total operating lease liabilities, current

Ordinary shares to be issued to Everest
Deferred subsidy income
Pro Forma
Total deferred subsidy income
Current liabilities of discontinued operations
Pro Forma
Total current liabilities
Convertible promissory notes
Pro Forma
Total convertible promissory notes
Put right liabilities, non-current
Put right liabilities
Contract liabilities, non-current
Operating lease liabilities, non-current
Pro Forma
Total operating lease liabilities, non-current

Other non-current liabilities
Non-current liabilities of discontinued operations

Liabilities
Pro Forma
Total liabilities

Mezzanine equity
Series A Convertible Preferred Shares
Series B Convertible Preferred Shares
Series C Convertible Preferred Shares
Series C-1 Convertible Preferred Shares
Total mezzanine equity
Shareholders' equity
Ordinary shares ($0.0001 par value, 800,000,000 shares authorized as of December 31, 2025 and 2024; 265,377,891 and 187,452,495 shares issued and outstanding as of December 31, 2025 and 2024, respectively)
Pro Forma
Total ordinary shares ($0.0001 par value, 800,000,000 shares authorized as of December 31, 2025 and 2024; 265,377,891 and 187,452,495 shares issued and outstanding as of December 31, 2025 and 2024, respectively)

Treasury stock
Additional paid-in capital
Pro Forma
Total additional paid-in capital

Accumulated other comprehensive income
Pro Forma
Total accumulated other comprehensive income

Accumulated deficit
Pro Forma
Total accumulated deficit

Pro Forma
Total shareholders' equity

Pro Forma
Total liabilities and shareholders' equity

Comments